MARKET

BCTXL

BCTXL

Briacell Therapeutics Corp
NASDAQ
1.050
-0.010
-0.94%
Closed 15:43 02/09 EST
OPEN
1.125
PREV CLOSE
1.050
HIGH
1.200
LOW
1.050
VOLUME
7.98K
TURNOVER
--
52 WEEK HIGH
1.400
52 WEEK LOW
0.6500
MARKET CAP
--
P/E (TTM)
-0.0197
1D
5D
1M
3M
1Y
5Y
1D
BriaCell Therapeutics Reports Tumor Regression in Phase 2 Study of Bria-IMT for Metastatic Breast Cancer
Reuters · 01/28 12:30
BRIACELL PATIENTS’ IMAGES SHOW REGRESSION AND RESOLUTION OF METASTASIZED TUMORS AND IMMUNE ACTIVATION
Reuters · 01/28 12:30
BriaCell Reports Extended Survival in Phase 2 Metastatic Breast Cancer Trial
Reuters · 01/27 17:05
BriaCell Highlights Extended >18-47 MONTHS SURVIVAL IN PHASE 2 METASTATIC BREAST CANCER PATIENTS
Reuters · 01/27 12:30
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
Barchart · 01/27 06:30

Webull offers undefined stock information, including NASDAQ: BCTXL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXL stock methods without spending real money on the virtual paper trading platform.